The German Ministry of Health has recently published its final bill concerning pricing and market ac...
Read moreBiosimilars have the potential to be considered comparable to generics and offer healthcare benefits...
Read moreNICE propose to charge to conduct single technology appraisals from May 2017.
Read moreInternational Reference Pricing (IRP) is a means to control national prices by using prices in other...
Read moreThe latest policy document for the European Commission outlines multiple scenarios for HTA harmonisa...
Read moreThe German Ministry of Health has recently published its final bill concerning changes to the market...
Read moreEnabling physicians to identify patients who are most likely to respond to treatment thereby achievi...
Read moreOver the next two years changes to the marketing authorisation or pricing and reimbursement procedur...
Read morePharma companies must start preparing its NICE submission at the time of making the regulatory subm...
Read moreA best practice guide for companies seeking parallel scientific HTA advice has been published by the...
Read more